Etravirine and Rilpivirine: Nonnucleoside Reverse Transcriptase Inhibitors with Activity Against Human Immunodeficiency Virus Type 1 Strains Resistant to Previous Nonnucleoside Agents-Reference-Cited by-同舟云学术

Etravirine and Rilpivirine: Nonnucleoside Reverse Transcriptase Inhibitors with Activity Against Human Immunodeficiency Virus Type 1 Strains Resistant to Previous Nonnucleoside Agents

Published:2009-03 Issue:3 Volume:29 Page:281-294
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Fulco Patricia Pecora,McNicholl Ian R

Publisher

Wiley

Subject

Pharmacology (medical)

Reference20 articles.

1. Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

2. Prevalence of Primary HIV‐1 Drug Resistance among Recently Infected Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study

3. Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

4. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

5. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs);Viruses;2023-09-25

2. Lipid nanocarrier targeting activated macrophages for antiretroviral therapy of HIV reservoir;Nanomedicine;2023-08

3. Advances in the Synthesis of Diarylpyrimidine as Potent Non-nucleoside Reverse Transcriptase Inhibitors: Biological Activities, Molecular Docking Studies and Structure-activity Relationship: A Critical Review;Current Organic Chemistry;2023-04

4. Ultrasonic energy for construction of bioactive heterocycles;Tetrahedron;2022-08

5. Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection;Annals of Pharmacotherapy;2021-02-16